Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
Ferri C, Giuggioli D, Raimondo V, L'Andolina M, Tavoni A, Cecchetti R, Guiducci S, Ursini F, Caminiti M, Varcasia G, Gigliotti P, Pellegrini R, Olivo D, Colaci M, Murdaca G, Brittelli R, Mariano GP, Spinella A, Bellando-Randone S, Aiello V, Bilia S, Giannini D, Ferrari T, Caminiti R, Brusi V, Meliconi R, Fallahi P, Antonelli A; COVID-19 & ASD Italian Study Group. Ferri C, et al. Among authors: giannini d. Clin Rheumatol. 2020 Nov;39(11):3195-3204. doi: 10.1007/s10067-020-05334-7. Epub 2020 Aug 27. Clin Rheumatol. 2020. PMID: 32852623 Free PMC article.
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study.
Ferri C, Giuggioli D, Raimondo V, Dagna L, Riccieri V, Zanatta E, Guiducci S, Tavoni A, Foti R, Cuomo G, De Angelis R, Cozzi F, Murdaca G, Cavazzana I, Romeo N, Codullo V, Ingegnoli F, Pellegrini R, Varcasia G, Rossa AD, De Santis M, Abignano G, Colaci M, Caminiti M, L'Andolina M, Lubrano E, Spinella A, Lumetti F, De Luca G, Bellando-Randone S, Visalli E, Bilia S, Giannini D, Masini F, Pellegrino G, Pigatto E, Generali E, Dall'Ara F, Mariano GP, Barsotti S, Pettiti G, Zanframundo G, Brittelli R, Aiello V, Scorpiniti D, Ferrari T, Caminiti R, Campochiaro C, D'Angelo S, Iannone F, Matucci-Cerinic M, Doria A, Miccoli M, Fallahi P, Antonelli A; COVID-19 & Autoimmune Systemic Diseases Italian Study Group. Ferri C, et al. Among authors: giannini d, d angelo s. Lancet Rheumatol. 2021 Mar;3(3):e166-e168. doi: 10.1016/S2665-9913(21)00007-2. Epub 2021 Jan 12. Lancet Rheumatol. 2021. PMID: 33521657 Free PMC article. No abstract available.
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments.
Ferri C, Giuggioli D, Raimondo V, L'Andolina M, Dagna L, Tavoni A, Caso F, Ursini F, Ruscitti P, Caminiti M, Foti R, Riccieri V, Guiducci S, Pellegrini R, Zanatta E, Varcasia G, Olivo D, Gigliotti P, Cuomo G, Murdaca G, Cecchetti R, De Angelis R, Romeo N, Ingegnoli F, Cozzi F, Codullo V, Cavazzana I, Colaci M, Abignano G, De Santis M, Lubrano E, Fusaro E, Rossa AD, Spinella A, Lumetti F, De Luca G, Bellando-Randone S, Visalli E, Dal Bosco Y, Amato G, Giannini D, Bilia S, Masini F, Pellegrino G, Pigatto E, Generali E, Mariano GP, Pettiti G, Zanframundo G, Brittelli R, Aiello V, Caminiti R, Scorpiniti D, Ferrari T, Campochiaro C, Brusi V, Fredi M, Moschetti L, Cacciapaglia F, Gragnani L, Monti M, Lorini S, Paparo SR, Ragusa F, Mazzi V, Elia G, Ferrari SM, Di Cola I, Vadacca M, Lorusso S, Barsotti S, Aprile ML, Marco T, Miccoli M, Bosello S, Matucci-Cerinic M, D'Angelo S, Doria A, Franceschini F, Meliconi R, Iannone F, Giacomelli R, Zignego AL, Fallahi P, Antonelli A. Ferri C, et al. Among authors: giannini d, d angelo s. Curr Pharm Des. 2021;27(41):4245-4252. doi: 10.2174/1381612827666210903103935. Curr Pharm Des. 2021. PMID: 34477509
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies.
Ferri C, Raimondo V, Gragnani L, Giuggioli D, Dagna L, Tavoni A, Ursini F, L'Andolina M, Caso F, Ruscitti P, Caminiti M, Foti R, Riccieri V, Guiducci S, Pellegrini R, Zanatta E, Varcasia G, Olivo D, Gigliotti P, Cuomo G, Murdaca G, Cecchetti R, De Angelis R, Romeo N, Ingegnoli F, Cozzi F, Codullo V, Cavazzana I, Colaci M, Abignano G, De Santis M, Lubrano E, Fusaro E, Spinella A, Lumetti F, De Luca G, Bellando-Randone S, Visalli E, Bosco YD, Amato G, Giannini D, Bilia S, Masini F, Pellegrino G, Pigatto E, Generali E, Mariano GP, Pettiti G, Zanframundo G, Brittelli R, Aiello V, Caminiti R, Scorpiniti D, Ferrari T, Campochiaro C, Brusi V, Fredi M, Moschetti L, Cacciapaglia F, Paparo SR, Ragusa F, Mazzi V, Elia G, Ferrari SM, Di Cola I, Vadacca M, Lorusso S, Monti M, Lorini S, Aprile ML, Tasso M, Miccoli M, Bosello S, D'Angelo S, Doria A, Franceschini F, Meliconi R, Matucci-Cerinic M, Iannone F, Giacomelli R, Salvarani C, Zignego AL, Fallahi P, Antonelli A. Ferri C, et al. Among authors: giannini d, d angelo s. Curr Pharm Des. 2022;28(24):2022-2028. doi: 10.2174/1381612828666220614151732. Curr Pharm Des. 2022. PMID: 35726427
One year in review 2020: pathogenesis of rheumatoid arthritis.
Giannini D, Antonucci M, Petrelli F, Bilia S, Alunno A, Puxeddu I. Giannini D, et al. Clin Exp Rheumatol. 2020 May-Jun;38(3):387-397. doi: 10.55563/clinexprheumatol/3uj1ng. Epub 2020 Apr 23. Clin Exp Rheumatol. 2020. PMID: 32324123 Free article. Review.
One year in review 2021: pathogenesis of rheumatoid arthritis.
Testa D, Calvacchi S, Petrelli F, Giannini D, Bilia S, Alunno A, Puxeddu I. Testa D, et al. Among authors: giannini d. Clin Exp Rheumatol. 2021 May-Jun;39(3):445-452. doi: 10.55563/clinexprheumatol/j1l5l3. Epub 2021 May 21. Clin Exp Rheumatol. 2021. PMID: 34018918 Free article. Review.
Efficacy and safety of omalizumab therapy in urticaria vasculitis.
Petrelli F, Giannini D, Bilia S, Corso ID, Rocchi V, Migliorini P, Puxeddu I. Petrelli F, et al. Among authors: giannini d. Front Allergy. 2022 Jul 22;3:952079. doi: 10.3389/falgy.2022.952079. eCollection 2022. Front Allergy. 2022. PMID: 35935020 Free PMC article.
Long-term efficacy, safety, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin (Ig) (fSCIG; HyQvia(®)) in immunodeficiency diseases: real-life data from a monocentric experience.
Angelotti F, Capecchi R, Giannini D, Mazzarella O, Rocchi V, Migliorini P. Angelotti F, et al. Among authors: giannini d. Clin Exp Med. 2020 Aug;20(3):387-392. doi: 10.1007/s10238-020-00633-4. Epub 2020 May 8. Clin Exp Med. 2020. PMID: 32385734
176 results